Change Location × Las Vegas

    Recent Locations

      9th International Conference & Exhibition on Tissue Science & Regenerative Medicine (CSE) in Las Vegas

      • 9th International Conference & Exhibition on Tissue Science & Regenerative Medicine (CSE) Photo #1
      1 of 1
      April 23, 2018

      Monday   9:00 AM

      3400 Paradise Road
      Las Vegas, Nevada 89169

      • No Performers Listed
      9th International Conference & Exhibition on Tissue Science & Regenerative Medicine (CSE)

      About Conference Conference Series extends warm invitation to all the participants across the globe to attend 9th International Conference & Exhibition on Tissue Science & Regenerative Medicine during April 23-24, 2018 in Las Vegas, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Regenerative Medicine 2018 is an unprecedented event designed for international medical health professionals and tissue scientists to facilitate the propagation and application of research findings related to the science of regeneration and all the associated research areas. The conference invites participants from universities, clinical research institutions and pharmaceutical companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques. Conference series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members. Reasons to Attend Edifying public with recent advances in tissue science and all the associated research areas from around the world, this is your single best opportunity to reach the largest congregation of participants. World-renowned speakers, the most recent techniques and the newest updates in Tissue science and all the associated research areas are pledges of this conference. Conferences, National symposium and Workshops provide a steadfast forum for the advancement, execution and exchange of information about the research done in the labs. Who Can Attend? Ø Tissue scientistsØ DoctorsØ Prosthetic surgeonsØ AcademiciansØ Academic scientistsØ OncologistØ Industry professionalsØ Diagnostic laboratory professionalsØ Postgraduate studentsØ Postdoctoral fellows and Trainees Ø Stem cell researchers. Importance and Scope With increase in the demand of organs and lack of supply of the same, scientists have been propelled to research more upon the science of regeneration so that this bridge between demand and supply is gapped. Tissue regeneration is a well-known phenomenon. This natural event has been utilized for regenerating lost parts of human being. Many advances have been taking place. With advent of regenerative medicine, the scenario has changed a lot. More over nanotechnology has added new dimension to the field of tissue engineering. Bio-printing of organs are also now possible with definite accuracy. These novel techniques can help mass to overcome the problems of lost organs. Many diseases can be cured. Regenerative Medicine 2018 aims to spread the inventions taking place inside the lab among more people. This will enable scientists to find answers they have been searching for. The business entrepreneurs can bring it to the market and the students can get inspired to learn more and work towards benefit of mankind. Today the market analysis of this field indicates that Government, private institutes and many others are investing more in this field as this has assuring future. The industrial output from the scientific developments in this filed are promising. Market Analysis Introduction Global tissue engineering market size is estimated to be around $60.8 billion by 2021 from $13.6 billion in 2016. Escalating need to bridge the gap of demand and lack of supply of organs is a strategic factor contributing to market growth of tissue science. Application of tissue engineering was initially restricted to surgical implantations and prosthetics. But now it includes cardiac, corneal, liver tissue engineering and regenerative medicine. For clinical trials and toxicity testing, animal models are used which have raised ethical and legal concerns. This necessitates the use of in-vitro testing. Tissue engineering gives the scope of using human equivalent models. An instance of this has been demonstrated by European Centre for the Validation of Alternative Methods to Animal Testing (ECVAM). They tend to use skin tissues instead of mice and rat models. But they still face challenges which need to be overcome. Industries are paying attention to the R&D of this sector. The Government bodies are strictly regulating the marketing of the therapies as many unproven products are coming up in the market. The field of regenerative medicine has expanded to cover from orthopedics to cancer. Increasing demand, technological advancements and research funding has helped in the market growth of this sector. The Market Value The market was dominated by orthopedic application during 2014 due to increasing number of reconstructive and replacement surgeries. The need for bone implants arises from the aging population and the increasing number of accidents. Tissue engineered devices efficiently fill the gap between the demand and the lack of supply of orthopedic products. The presence of leading international players and US government support has helped flourish the market of tissue engineering in North America rendering it the highest position. Private investors play important roles too. The U.S. Department of Health and Human services state that USD 4 billion pounds have been invested in private capital for regenerative medicine. Initiated in 2006, the expanse of the market has seen dramatic rise. Proteus Fund in California is focusing on tissue engineering and aesthetic medicines. Industry and academic institutes are working hand in hand to render proper service to the mass. Cesca Therapeutics, Inc. and Center for Immune Cell Therapies (CICT) teamed up to investigate the application of AutoXpress platform for immune cell therapy in September 2015. 3D printing technology is in demand to lessen the cost and errors in tissue engineered scaffolds. Industry players are continuously working to enhance the present 3D technology and thereby rendering better organ and tissue printing. 3Dynamic Systems Ltd. (3DS) launched two new 3D printers named Omega and Alpha bio printers in September 2014. The company is currently fabricating bone and complex tissues by using the bio-printer. Asia Pacific presents a wide opportunity for tissue engineering and regenerative medicines due to the presence of huge manpower, technology and government funding. In addition, increasing industry-academia alliances and acquisitions by international companies are expected to propel the demand for these therapies. The demand for the human cells has also fuelled the interest of tycoons from the pharmaceutical industry. April 2015 witnessed Takeda Pharmaceutical Company Limited and Center for iPS Cell Research Application (CiRA) sign a ten-year collaborative research agreement. Through the academia-industry collaboration, both the parties will expand clinical applications, where they can use human pluriponent cells for heart failure. Moreover in  December 2015, Pandorum Technologies Pvt., Ltd. manufactured its first 3D printed artificial human tissue. The artificial liver performs all the critical functions such as secretion, detoxification, and metabolism. Some key industries in this sector include Medtronic, Inc., Zimmer Biomet, Acelity, Athersys, Inc., Organogenesis, Inc, Stryker Corporation, Tissue Regenix Group Plc and RTI surgical, Inc. Speakers Byungse Suh Temple University School of Medicine, USA Hartmut Derendorf University of Florida, USA John Cadwell FiberCell Systems Inc, USA Tadashi Shimamoto Hiroshima University, Japan Surbhi Malhotra Kumar University of Antwerp, Belgium Samir Kumar-Singh University of Antwerp, Belgium Siham M Mahgoub Alzahra Hospital Dubai, UAE Andrea Barbarossa University of Bologna, Italy Georg Daeschlein University Medicine Greifswald, Germany Myung-Soo Kang iNtRON Biotechnology, South Korea Glenn S Tillotson TranScrip Partners LLC, USA Jeffery H Miller University of California, USA John M Clerici Tiber Creek Partners, LLC, USA Kenneth M Bischoff U.S. Department of Agriculture, USA Martin Duerden Bangor University, UK Michael kelso University of Wollongong, Australia Suresh Joshi Drexel University College of Medicine, USA Yuxiu Lei Lahey Hospital and Medical Center, USA Kevin Schrader United States Department of Agriculture, USA Johnelle R. Whipple Reckitt Benckiser, USA Mario A Bianchet Johns Hopkins School of Medicine, USA Herbert B. Allen Drexel University College of Medicine, USA Pietro Mastroeni University of Cambridge, UK Christof Berberich Heraeus-Medical GmbH, Germany Richard W Titball University of Exeter, UK Georgios A Delis Aristotle University of Thessaloniki, , Greece Oleg N Reva University of Pretoria, South Africa Andrei L. Gartel University of Illinois at Chicago, USA Marco Manfredi Pietro Barilla Children Hospital Parma, Italy Anna Malm Medical University of Lublin, Poland Adrian Shephard Reckitt Benckiser, UK Marc Devocelle Royal College of Surgeons in Ireland, Ireland Ganjun Yuan Jiangxi Agricultural University, China Khine Swe Swe Han University of KwaZulu-Natal, South Africa Douglas Burgoyne Veridicus Health, USA Agenda Please contact the event manager Marilyn below for the following: - Discounts for registering 5 or more participants.- If you company requires a price quotation.Event Manager Contact: marilyn.b.turner(at)nyeventslist.comYou can also contact us if you require a visa invitation letter, after ticket purchase. We can also provide a certificate of completion for this event if required.NO REFUNDS ALLOWED ON REGISTRATIONS -----------------------------------------------------------------This Event Listing is Promoted byNew York Media Technologies LLC in associationwith Conferenceseries Ltd.http://www.NyEventsList.comhttp://www.BostonEventsList.com SHU171226CEV

      Categories: Science

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.